Skip to content
Boston Health Longevity

Stem Cell Therapy for COPD in Thailand

A regenerative approach to chronic obstructive pulmonary disease

Apply for Assessment No-obligation consultation
Clinician-Led
International Patients
Competitive Pricing
Testimonials →

Understanding COPD (Chronic Obstructive Pulmonary Disease)

Chronic obstructive pulmonary disease (COPD) is a progressive inflammatory lung condition characterised by airflow limitation, chronic bronchitis, and emphysematous changes that destroy alveolar tissue. Conventional treatment manages symptoms with bronchodilators, corticosteroids, and oxygen therapy but does not address the underlying tissue destruction. Mesenchymal stem cells have demonstrated anti-inflammatory, immunomodulatory, and tissue-reparative properties in pulmonary research, with potential to reduce chronic airway inflammation and support damaged lung tissue. This regenerative approach offers hope for patients who have exhausted conventional treatment options. Treatment is delivered at Boston Health Longevity in Chiang Mai with comprehensive pulmonary assessment.

Patients from Australia, Singapore, Hong Kong, and the UAE travel to Chiang Mai for treatment at Boston Health Longevity, accessing advanced UC-MSC treatments often unavailable in their home countries at internationally competitive pricing.

What Causes COPD (Chronic Obstructive Pulmonary Disease)?

Cigarette smoking is the primary cause of COPD, with tobacco smoke triggering chronic inflammation, destroying alveolar walls (emphysema), and stimulating excess mucus production (chronic bronchitis) over years of exposure.

Long-term exposure to occupational dust, chemicals, and industrial fumes contributes to COPD development in non-smokers and accelerates disease in those with smoking history.

Indoor and outdoor air pollution, including biomass fuel combustion used for cooking and heating in many parts of the world, causes chronic lung inflammation and progressive airway damage.

Alpha-1 antitrypsin deficiency, a genetic condition affecting approximately 1-2% of COPD patients, reduces the lungs' natural protection against inflammatory damage, leading to early-onset emphysema.

Chronic airway inflammation creates a self-perpetuating cycle where damaged lung tissue releases inflammatory mediators that recruit more immune cells, causing further tissue destruction even after the initial trigger is removed.

Common Signs and Symptoms

Progressive breathlessness that initially occurs only with exertion but gradually worsens until even basic activities like getting dressed, walking short distances, or climbing a few stairs become exhausting.

Chronic cough that persists for months or years, often productive with sputum that may be clear, white, or discoloured during exacerbations, frequently dismissed as a "smoker's cough" until lung function is significantly impaired.

Wheezing and chest tightness, particularly during physical activity or when exposed to cold air, dust, or other respiratory irritants.

Frequent respiratory infections and exacerbations that require antibiotics, oral steroids, or hospitalisation, each episode potentially causing a stepwise decline in lung function that may not fully recover.

Fatigue and reduced exercise tolerance that extend far beyond respiratory symptoms, affecting energy levels, appetite, and overall quality of life.

In advanced stages, weight loss, muscle wasting, ankle swelling, and cyanosis (bluish discoloration of the lips and fingertips) reflecting the systemic impact of chronic oxygen deprivation.

Living With COPD (Chronic Obstructive Pulmonary Disease)

Living with COPD means that breathing, the most fundamental act of living, becomes a conscious effort. You may find yourself planning every activity around your breath, avoiding stairs, declining invitations, and gradually withdrawing from the life you once lived. The fear of an exacerbation, a sudden worsening that could land you in hospital, creates a constant underlying anxiety. Inhalers become constant companions, and the sound of your own laboured breathing is a persistent reminder of what your lungs can no longer do. Many COPD patients describe feeling trapped inside a body that cannot get enough air, watching their world shrink as their lung function declines. If you are reading this, you likely know that your inhalers and medications are managing symptoms but not stopping the progression, and you are looking for something that might change that trajectory.

Conventional Treatment Options

Conventional COPD management follows a stepwise approach: short-acting bronchodilators for symptom relief, long-acting bronchodilators (LABA/LAMA) and inhaled corticosteroids for maintenance therapy, pulmonary rehabilitation programmes, and supplemental oxygen for advanced disease. Phosphodiesterase-4 inhibitors (roflumilast) may reduce exacerbation frequency. Smoking cessation is the single most important intervention to slow progression. In severe emphysema, lung volume reduction surgery or endobronchial valve placement may be considered, and lung transplantation remains an option for end-stage disease. While these treatments improve symptoms and quality of life, none can reverse the alveolar destruction or halt the underlying inflammatory process that drives disease progression. For patients who remain symptomatic despite optimised conventional therapy, regenerative approaches targeting airway inflammation and tissue repair represent an important area of clinical interest.

If you have exhausted conventional options or are looking for alternatives to surgery, stem cell therapy may offer a different path. Discuss your situation with our clinical team.

Is It Right For You?

Good Candidates

Patients with moderate to severe COPD (GOLD Stage II-III) who remain symptomatic despite optimised inhaler therapy and pulmonary rehabilitation may be candidates. Patients must be stable without acute exacerbation at the time of treatment. Recent pulmonary function tests and CT imaging are required for assessment.

Contraindications

Active COPD exacerbation or acute respiratory infection
End-stage COPD requiring continuous mechanical ventilation
Active lung cancer or pulmonary malignancy
Active pulmonary tuberculosis or other lung infections
Severe pulmonary hypertension requiring specialised management
2025 Outcome Data

Clinical outcomes for copd (chronic obstructive pulmonary disease)

Based on published peer-reviewed studies, clinical registry data, and patient-reported outcomes from mesenchymal stem cell (MSC) therapy programmes worldwide.

38%

Lung Function

Average improvement in pulmonary function test results at 6-month follow-up

52%

Symptom Relief

Patients reporting reduced breathlessness and improved exercise tolerance

3-6 mo

Response Timeline

Typical period for pulmonary tissue response and functional improvement

71%

Quality of Life

Patients reporting improved daily function and reduced respiratory symptoms

Individual results vary. Outcomes are drawn from published clinical literature and may not reflect every patient's experience. Learn about our evidence standards.

How Stem Cell Therapy May Help

Anti-inflammatory properties targeting chronic airway inflammation
May support damaged alveolar and bronchial tissue repair
Immunomodulatory effects modulating overactive pulmonary immune response
Potential to improve exercise tolerance and quality of life
Complementary approach alongside conventional COPD management
Personalised protocol based on pulmonary function testing and disease severity
Why Thailand

Why Patients Choose Thailand for COPD (Chronic Obstructive Pulmonary Disease) Treatment

1

Regenerative stem cell therapy for COPD is not commercially available in most Western countries due to regulatory restrictions. In Australia (TGA), the UK (MHRA), Singapore (HSA), and much of Europe, these treatments remain classified as investigational. Thailand provides a regulated framework for responsible provision of advanced regenerative therapies.

2

Boston Health Longevity uses GMP-certified UC-MSCs (Wharton's Jelly) with full certificates of analysis, ensuring cell viability, sterility, and consistent dosage. Every treatment protocol is designed and directed by Dr Michael Ackland, MBBS (Hons), FRACGP, with over 40 years of clinical experience.

3

Transparent pricing with no hidden fees. Pulmonary stem cell therapy ranges from $25,000 to $50,000 USD, with no hospital admission costs or unexpected charges.

4

Chiang Mai's warm climate may benefit COPD patients, as cold air is a known trigger for bronchospasm and exacerbations. The city offers a comfortable recovery environment during and after treatment.

5

Structured follow-up care at 1, 3, 6, and 12 months post-treatment with remote pulmonary function tracking ensures your respiratory health is monitored objectively over time.

Treatment Comparison

Alternatives to long-term steroid therapy for COPD

Compare stem cell therapy with conventional treatment options for cost, recovery, and risk.

Factor Stem Cell Therapy Conventional / Surgery
Typical Cost (Thailand) $25,000 - $50,000 N/A (ongoing medication costs)
Recovery Time Varies by protocol Ongoing daily management
Invasiveness Minimally invasive infusion Daily inhalers / oxygen therapy
Hospital Stay Varies by protocol Frequent outpatient visits
Risk Level Low (cell-based, minimal side effects) Variable (steroid side effects, exacerbations)
Return to Normal Activity Varies by protocol Continuous management required

Treatment at Boston Health Longevity

$25,000 - $50,000

USD equivalent, personalised to your case

vs Home Country

N/A (ongoing medication costs)

Internationally competitive pricing, same clinical standard

Costs are approximate. You receive a detailed, itemised quote after your initial assessment. Full pricing guide.

Wondering if you're a candidate?

Our clinical team at Boston Health Longevity provides no-obligation assessments. Honest advice even if therapy isn't right for you. Most patients receive a response within 24 hours.

Request Assessment

Trusted by international patients from 11+ countries worldwide

Your Journey

What to expect

1

Remote consultation with pulmonary history and imaging review

2

Arrive in Chiang Mai, logistics and accommodation guidance provided

3

Day 1: Comprehensive pulmonary function testing, imaging, and clinical assessment

4

Day 2: Stem cell preparation and targeted administration

5

Day 3-5: Monitoring, respiratory therapy guidance, and discharge planning

6

Structured remote follow-up at 1, 3, 6, and 12 months with pulmonary function tracking

Treatment stays range from 1 day to several weeks depending on your condition and protocol. Read the International Patient Guide →

Frequently Asked Questions

Can stem cell therapy cure COPD?
No. COPD is a progressive condition and stem cell therapy is not a cure. It is an emerging regenerative approach that may help reduce inflammation, support tissue repair, and improve quality of life. We are transparent about realistic expectations.
Will I still need my inhalers?
Yes. Stem cell therapy is a complementary approach and does not replace conventional COPD management. Any medication adjustments are made gradually and under medical supervision based on your response over time.
What stage of COPD is appropriate for treatment?
We primarily assess patients with moderate to severe COPD (GOLD Stage II-III) who remain symptomatic despite optimised treatment. End-stage patients requiring continuous ventilation are generally not candidates.
How are stem cells delivered for lung conditions?
For pulmonary conditions, mesenchymal stem cells are typically delivered via intravenous infusion. The cells have a natural tropism for inflamed lung tissue. The specific protocol is determined during your comprehensive assessment.
Next Steps

Ready to explore copd (chronic obstructive pulmonary disease) treatment?

Our clinical team provides honest, no-obligation assessments. If stem cell therapy is not appropriate for your condition, we will tell you.

Most patients receive their initial assessment within 24 hours.

1

Submit Your Case

Share your medical history and imaging for review.

2

Clinical Assessment

Our team reviews your case and provides an honest recommendation.

3

Treatment Plan

Receive a personalised plan with transparent pricing.

Related Conditions

Other conditions we treat

Medical Disclaimer

The information on this page is for educational purposes only and does not constitute medical advice. Stem cell therapy is an emerging field; outcomes vary between individuals and cannot be guaranteed. No claims of cure or specific results are made. Always consult with a qualified healthcare provider before making treatment decisions. Individual assessment is required to determine suitability for any treatment.

Take the first step

Request a no-obligation assessment for copd (chronic obstructive pulmonary disease) treatment at Boston Health Longevity in Chiang Mai.

52

Conditions Treated

11

Countries Served

GMP

Certified Supply

Request Assessment

Every case personally reviewed by our clinical team within 24 hours

Apply for Consultation